At a glance
ClinicalIndex Comparison RecordN/ACompleted· 8 enrolled
Drug / intervention
OxyGenesys Dissolved Oxygen Dressingdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective, Randomized, Single Center, Controlled Evaluation of the Effectiveness of OxyGenesys Topical Dissolved Oxygen Dressing in Accelerating the Healing of Split Thickness Skin Graft Donor Sites Using the NWU Abdominoplasty Scar Model
In Brief
A clinical study evaluating OxyGenesys Dissolved Oxygen Dressing for Wounds. Completed, enrolled 8 participants across 1 site.
Detailed Summary
Twelve acute wounds (6 on either side of the umbilicus) will be surgically created in the lower abdominal area. One side of the umbilicus will be randomized to Oxygenesys treatment arm and the other side will be receiving a standard Tegaderm treatment arm. Time to wound healing will be observed over 14 days.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsWounds
CountriesUnited States
CollaboratorsNorthwestern University
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartOct 2015
First PostedOct 2015
Primary CompletionSep 2016
TodayJul 2026
First PostedOct 29, 2015
Enrollment StartOct 1, 2015
Primary CompletionSep 1, 2016
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 10.7 years ago
Interventions
OxyGenesys Dissolved Oxygen Dressingdevice
1/2 of the abdominal wounds will be covered with Oxygenesys Dissolved Dressing.